BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
0.00%
(0.00) 1D
Nov 18, 4:10:16 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
10.87M
Volume
29.97M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
10.87M
Volume
29.97M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Barron's
·
1 hour ago
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
BigGo Finance
·
2 hours ago
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
FOREX.com
·
1 hour ago
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Traders Union
·
2 hours ago
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com